Terms: = Kidney tumors AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF
15 results:
1. Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.
Parsons MW; Rock C; Chipman JJ; Shah HR; Hu B; Stephens DM; Tao R; Tward JD; Gaffney DK
Cancer Med; 2023 Feb; 12(3):2624-2636. PubMed ID: 36812123
[TBL] [Abstract] [Full Text] [Related]
2. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
[TBL] [Abstract] [Full Text] [Related]
3. Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance.
Tan SK; Mahmud I; Fontanesi F; Puchowicz M; Neumann CKA; Griswold AJ; Patel R; Dispagna M; Ahmed HH; Gonzalgo ML; Brown JM; Garrett TJ; Welford SM
Cancer Discov; 2021 Aug; 11(8):2072-2093. PubMed ID: 33757970
[TBL] [Abstract] [Full Text] [Related]
4. Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies.
Sheng X; Jin J; He Z; Huang Y; Zhou A; Wang J; Ren X; Ye D; Zhang X; Qin S; Zhou F; Wang B; Guo J
BMC Cancer; 2020 Mar; 20(1):219. PubMed ID: 32171288
[TBL] [Abstract] [Full Text] [Related]
5. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract] [Full Text] [Related]
6. Large pleural tumor revealed by severe hypoglycemia: Doege-Potter syndrome.
Strâmbu IR; Leonte DG; Bolca CN
Rom J Morphol Embryol; 2017; 58(1):287-291. PubMed ID: 28523334
[TBL] [Abstract] [Full Text] [Related]
7. Association between non-Hodgkin lymphoma and renal cell carcinoma.
Lossos C; Ferrell A; Duncan R; Lossos IS
Leuk Lymphoma; 2011 Dec; 52(12):2254-61. PubMed ID: 21740306
[TBL] [Abstract] [Full Text] [Related]
8. Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.
Kunthur A; Wiernik PH; Dutcher JP
Am J Hematol; 2006 Apr; 81(4):271-80. PubMed ID: 16550521
[TBL] [Abstract] [Full Text] [Related]
9. Thyroid cancer and multiple primary tumors in the SEER cancer registries.
Ronckers CM; McCarron P; Ron E
Int J Cancer; 2005 Nov; 117(2):281-8. PubMed ID: 15880372
[TBL] [Abstract] [Full Text] [Related]
10. Antihypertensive therapy and the risk of malignancies.
Grossman E; Messerli FH; Goldbourt U
Eur Heart J; 2001 Aug; 22(15):1343-52. PubMed ID: 11465967
[TBL] [Abstract] [Full Text] [Related]
11. Incidence of second primary cancers in three Italian population-based cancer registries.
Buiatti E; Crocetti E; Acciai S; Gafà L; Falcini F; Milandri C; La Rosa M
Eur J Cancer; 1997 Oct; 33(11):1829-34. PubMed ID: 9470841
[TBL] [Abstract] [Full Text] [Related]
12. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
[TBL] [Abstract] [Full Text] [Related]
13. Cancer incidence in a population potentially exposed to radium-226 at Dalgety Bay, Scotland.
Black RJ; Sharp L; Finlayson AR; Harkness EF
Br J Cancer; 1994 Jan; 69(1):140-3. PubMed ID: 8286196
[TBL] [Abstract] [Full Text] [Related]
14. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
[TBL] [Abstract] [Full Text] [Related]
15. Second cancers following non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Boice JD; Hankey BF; Fraumeni JF
Cancer; 1991 Apr; 67(7):2002-9. PubMed ID: 2004317
[TBL] [Abstract] [Full Text] [Related]
